Why Eli Lilly Stock Beat the Market Today While ResMed and AdaptHealth Sank

Before market open, Eli Lilly announced that its molecule tirzepatide had achieved its primary endpoints in a set of phase 3 clinical trials. The studies aimed to judge its efficacy in treating ... Read More

Latest Health News

Eli Lilly to Ask FDA to Approve Weight Loss Drug ... MINOCA: The Heart Attack You Didn’t See ComingIt's a heart attack without the blockages you'd expect. And it happens more often in women. Read More

Eli Lilly warns of shortage of insulin products

Drugmaker Eli Lilly & Co is announcing a temporary ... Medicaid coverage say they're now without any health insurance, a new survey finds. Health News // 3 days ago Rate of permanent ... Read More

Eli Lilly Warns That 2 Insulin Products Will Be in Short Supply

Eli Lilly Warns That 2 Insulin Products Will Be in Short Supply By Ernie Mundell and Carole Tanzer Miller HealthDay Reporters MONDAY, March 25, 2024 (HealthDay News) -- Drugmaker Eli Lilly & Co is ... Read More

Prescriptions for Eli Lilly's newly-approved weight-loss drug Zepbound overtake Wegovy for the first time - with nearly 150,000 new patients now filling a script for the shots ...

There were 77,590 new scripts written in the US for Eli Lilly's Zepbound during the week ending March 8 - around 6,000 more than its rival. However, there were still more overall prescriptions for ... Read More

ELI LILLY

US FDA gives second approval to Eli Lilly's drug for type of blood cancer The company said the health regulator gave ... platform Follow us for the latest news, insider access to events and ... Read More

Eli Lilly and Company (LLY)

Eli Lilly and Company (NYSE: LLY) will participate in Cowen's 44th Annual Health Care Conference on ... Philip Johnson, group vice president and treasurer, will retire from the company at the ... Read More

Here's How Much You Would Have Made Owning Eli Lilly and Co Stock In The Last 5 Years

Eli Lilly and Co LLY has outperformed the market ... a price of $780.08 for LLY at the time of writing. Finally -- what's the point of all this? The key insight to take from this article is ... Read More

Medicare to Cover Wegovy When Patients Also Have Heart Disease

Medicare to Cover Wegovy When Patients Also Have Heart Disease By Robin Foster HealthDay Reporter FRIDAY, March 22, 2024 (HealthDay News ... Nordisk’s Ozempic and Eli Lilly’s Mounjaro ... Read More

Eli Lilly warns of temporary short supply of two insulin products

Drugmaker Eli Lilly ... people’s treatment regimens, and we are moving with urgency to address it.” People who have trouble getting their prescription filled should contact their health ... Read More

Eli Lilly and Co

We provide a platform for our authors to report on investments fairly, accurately, and from the investor’s point of view. We also respect individual opinions––they represent the unvarnished ... Read More

Here's How Much You Would Have Made Owning Eli Lilly and Co Stock In The Last 20 Years

Eli Lilly and Co LLY has outperformed the market ... a price of $750.68 for LLY at the time of writing. Finally -- what's the point of all this? The key insight to take from this article is ... Read More